Health Care M&A: Pfizer Acquires Excaliard; United Health Acquires XLHealth

Market News Video
November 22, 2011 AT 12:36 PM
Pfizer (PFE) said today it has agreed to acquire skin fibrosis treatment developer Excaliard Pharmaceuticals, for an undisclosed sum. The acquisition is part of Pfizer's corporate research and development strategy to complement its internal project pipeline with innovative and differentiated drugs from biotech partners, Pfizer's chief of research and development said.